Attack-related severity: a key factor in understanding the spectrum of idiopathic inflammatory demyelinating disorders

Siva, 1999, An introduction to the clinical spectrum of inflammatory demyelinating disorders of the central nervous system, vol. II, 1 Yaul, 1991, Destructive lesions in demyelinating disease, J. Neurol. Neurosurg. Psychiatry, 54, 288, 10.1136/jnnp.54.4.288 Poser, 1994, The epidemiology of multiple sclerosis: a general overview, Ann. Neurol., 36, S180, 10.1002/ana.410360805 O'Riordan, 1996, Clinical, CSF, and MRI findings in Devic's neuromyelitis optica, J. Neurol. Neurosurg. Psychiatry, 60, 382, 10.1136/jnnp.60.4.382 Wingerchuk, 1999, The clinical course of neuromyelitis optica (Devic's syndrome), Neurology, 53, 1107, 10.1212/WNL.53.5.1107 Fukazawa, 1998, The significance of oligoclonal bands in multiple sclerosis in Japan: relevance of immunogenetic backgrounds, J. Neurol. Sci., 158, 209, 10.1016/S0022-510X(98)00127-0 Lucchinetti, 2000, Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination, Ann. Neurol., 47, 707, 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q Oksenberg, 2001, Multiple sclerosis: genomic rewards, J. Neuroimmunol., 113, 171, 10.1016/S0165-5728(00)00444-6 Kikuchi, 2003, HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands, Neurology, 60, 647, 10.1212/01.WNL.0000048202.09147.9E Shibasaki, 1981, Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients, J. Neurol. Sci., 49, 253, 10.1016/0022-510X(81)90083-6 Kira, 1996, Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders, Ann. Neurol., 40, 569, 10.1002/ana.410400405 Fukazawa, 1992, Multiple sclerosis in Hokkaido, the northernmost island of Japan: prospective analyses of clinical features, Intern. Med., 31, 349, 10.2169/internalmedicine.31.349 Miyazawa, 2001, Neuromyelitis optica (Devic disease) and optic-spinal form multiple sclerosis, Brain Nerve (Japanese), 53, 901 Weinshenker, 2003, Neuromyelitis optica: what it is and what it might be, Lancet, 361, 889, 10.1016/S0140-6736(03)12784-5 Ikuta, 1976, Problems in the pathoanatomy of multiple sclerosis. Realities of multiple sclerosis pathology on the US and Japanese cases, 143 Ikuta, 1982, Comparison of multiple sclerosis pathology between 70 American and 75 Japanese autopsy cases, 297 Nakashima, 1999, Oligoclonal IgG bands in Japanese multiple sclerosis patients, J. Neuroimmunol., 101, 205, 10.1016/S0165-5728(99)00147-2 Yamasaki, 1999, HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies, Brain, 122, 1689, 10.1093/brain/122.9.1689 Fukazawa, 2000, Genomic HLA profiles of MS in Hokkaido, Japan: important role of DPB1*0501 allele, J. Neurol., 247, 175, 10.1007/s004150050558 Compston, 1995, Genes and susceptibility to multiple sclerosis, Acta Neurol. Scand., 43, 10.1111/j.1600-0404.1995.tb05855.x Fukazawa, 2000, Both the HLA-DPB1 and-DRB1 alleles correlate with risk for multiple sclerosis in Japanese: clinical phenotypes and gender as important factors, Tissue Antigens, 55, 199, 10.1034/j.1399-0039.2000.550302.x Fukazawa, 1990, Acute transverse myelopathy in multiple sclerosis, J. Neurol. Sci., 100, 217, 10.1016/0022-510X(90)90036-M Fukazawa, 1992, MRI findings of multiple sclerosis with acute transverse myelopathy, J. Neurol. Sci., 110, 27, 10.1016/0022-510X(92)90005-6 Fukazawa, 1994, Acute transverse myelopathy in MS: clinical considerations, Int. MS J., 1, 27 Fukazawa, 2003, Multiphasic demyelinating disorder with acute transverse myelitis in Japanese, J. Neurol., 250, 624, 10.1007/s00415-003-1056-6 Misu, 2002, Pure optic-spinal form of multiple sclerosis in Japan, Brain, 125, 2460, 10.1093/brain/awf260 McDonald, 2001, Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis, Ann. Neurol., 50, 121, 10.1002/ana.1032 Fukazawa, 1996, Antineutrophil cytoplasmic antibodies and the optic-spinal form of multiple sclerosis in Japan, J. Neurol. Neurosurg. Psychiatry, 61, 203, 10.1136/jnnp.61.2.203-a Buyse, 1993, Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization, Tissue Antigens, 41, 1, 10.1111/j.1399-0039.1993.tb01970.x Ito, 1998, HLA-DP-associated susceptibility to the optico-spinal form of multiple sclerosis in the Japanese, Tissue Antigens, 52, 179, 10.1111/j.1399-0039.1998.tb02282.x Ma, 1998, HLA-DRB1 and tumor necrosis factor gene polymorphisms in Japanese patients with multiple sclerosis, J. Neuroimmunol., 92, 109, 10.1016/S0165-5728(98)00189-1 Ono, 1998, Molecular analysis of HLA class I (HLA-A and B) and HLA class II (HLA-DRB1) genes in Japanese patients with multiple sclerosis (Western type and Asian type), Tissue Antigens, 52, 539, 10.1111/j.1399-0039.1998.tb03084.x Schmied, 1993, Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis: evidence for programmed cell death as a mechanism to control inflammation in the brain, Am. J. Pathol., 143, 446 Fukazawa, 1999, CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients, J. Neurol. Sci., 171, 49, 10.1016/S0022-510X(99)00251-8 Niino, 2002, An examination of the Apo-1/Fas promoter MvaI polymorphism in Japanese patients with multiple, BMC Neurol., 2, 1, 10.1186/1471-2377-2-8 Kira, 1999, Changes in the clinical phenotypes of multiple sclerosis during the 50 years in Japan, J. Neurol. Sci., 166, 53, 10.1016/S0022-510X(99)00115-X Nakashima, 1999, Decrease in multiple sclerosis with acute transverse myelitis in Japan, Tohoku J. Exp. Med., 188, 89, 10.1620/tjem.188.89 Lee, 1998, Molecular basis of T-cell inactivation by CTLA-4, Science, 282, 2263, 10.1126/science.282.5397.2263 Ligers, 2001, CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms, Genes Immun., 2, 145, 10.1038/sj.gene.6363752 Harbo, 1999, CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis, Tissue Antigens, 53, 106, 10.1034/j.1399-0039.1999.530112.x Ligers, 1999, The CTLA-4 is associated with multiple sclerosis, J. Neuroimmunol., 97, 182, 10.1016/S0165-5728(99)00072-7 Yanagawa, 2000, CTLA-4 gene polymorphism in Japanese patients with rheumatoid arthritis, J. Rheumatol., 27, 2740 Rasmussen, 2001, CTLA4 in multiple sclerosis. Lack of genetic association in a European Caucasian population but evidence of interaction with HLA-DR2 among Shanghai Chinese, J. Neurol. Sci., 184, 143, 10.1016/S0022-510X(00)00502-5 Bitsch, 2002, Differentiation of multiple sclerosis subtypes: implications for treatment, CNS drugs, 16, 405, 10.2165/00023210-200216060-00004 Mandler, 1998, Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine, Neurology, 51, 1219, 10.1212/WNL.51.4.1219